Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Minodronic acid

Next Previous
X
Search
Drug Profile

Minodronic acid

Alternative Names: Bonoteo Tablets; Minodron; Minodronate; ONO-5920; Onobis®; Recalbon Tablets; YH 529; YM 529

Latest Information Update: 19 Sep 2017

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Astellas Pharma
  • Developer Astellas Pharma; Ono Pharmaceutical
  • Class Antineoplastics; Bisphosphonates; Calcium regulators; Imidazoles; Osteoporosis therapies; Small molecules
  • Mechanism of Action Bone resorption factor inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Osteoporosis
  • Discontinued Cancer metastases; Hypercalcaemia; Multiple myeloma

Most Recent Events

  • 31 Aug 2017 Ono Pharmaceutical suspends patient enrolment in a phase II trial for Osteoporosis in Japan (PO) (UMIN000021242)
  • 16 Sep 2016 Pharmacokinetics data from preclinical studies in Osteoporosis was presented at the 38th Annual Meeting of the American Society for Bone and Mineral Research (ASBMR-2016)
  • 16 Sep 2011 Launched for Osteoporosis (intermittent therapy) in Japan (PO)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top